Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Transforming Growth Factor-β Signaling–Deficient Fibroblasts Enhance Hepatocyte Growth Factor Signaling in Mammary Carcinoma Cells to Promote Scattering and Invasion
2008
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
2001 Standout
Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer
2007
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Herceptin: mechanisms of action and resistance
2005
Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer
2004
Hallmarks of Cancer: The Next Generation
2011 Standout
Estrogen receptor mutations and their role in breast cancer progression
2014
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
1997
The DNA-damage response in human biology and disease
2009 StandoutNature
EGFR Antagonists in Cancer Treatment
2008 Standout
Base-excision repair of oxidative DNA damage
2007 StandoutNature
Treatment Decisions After Diagnosis of Metastatic Colorectal Cancer
2011
Expression of Musashi-1 in Human Normal Colon Crypt Cells: A Possible Stem Cell Marker of Human Colon Epithelium
2003
A view on drug resistance in cancer
2019 StandoutNature
Sulindac causes regression of rectal polyps in familial adenomatous polyposis
1991
Cell production rates in human tissues and tumours and their significance. Part II: clinical data
2000
The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
2002 Standout
Microsatellite Instability and High Content of Activated Cytotoxic Lymphocytes Identify Colon Cancer Patients with a Favorable Prognosis
2001
Immunohistochemical Study of Colorectal Tumors for Expression of a Novel Transmembrane Carbonic Anhydrase, MN/CA IX, with Potential Value as a Marker of Cell Proliferation
1998
The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis
1995
Functional characterization of human MutY homolog (hMYH) missense mutation (R231L) that is linked with hMYH-associated polyposis
2006
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017
Impact of Screening Program on Incidence of Colorectal Cancer: A Cohort Study in Italy
2015
Cancer drug resistance: an evolving paradigm
2013 Standout
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy: Report of 100 consecutive cases
2004 Standout
Telomere Dysfunction Increases Mutation Rate and Genomic Instability
2001 StandoutNobel
Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
1999 StandoutNobel
Telomere dysfunction and the initiation of genome instability
2003 StandoutNobel
MUTYH-associated polyposis—From defect in base excision repair to clinical genetic testing
2006
Assessment of a HER2 scoring system for gastric cancer: results from a validation study
2008
Colorectal cancer
2019 Standout
A randomized trial comparing wireless capsule endoscopy with push enteroscopy for the detection of small-bowel lesions
2000
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Is prophylactic colectomy indicated in patients with MYH‐associated polyposis?
2005
Colorectal cancer population screening programs worldwide in 2016: An update
2017
Immunity, Inflammation, and Cancer
2010 Standout
Emerging Biological Principles of Metastasis
2017 Standout
A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma
2013
Hereditary Colorectal Cancer
2003 Standout
EMT: 2016
2016 Standout
PI3K and MEK inhibitor combinations: examining the evidence in selected tumor types
2013
The impact of immunochemical faecal occult blood testing on colorectal cancer incidence
2013
Initial experience of wireless-capsule endoscopy for evaluating occult gastrointestinal bleeding and suspected small bowel pathology
2002
Cancer immunotherapy comes of age
2011 StandoutNature
Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial
2011
Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression
2000 StandoutNobel
Semaphorin 3E–Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism
2011
Small bowel polyps in Peutz-Jeghers syndrome: management by combined push enteroscopy and intraoperative enteroscopy
2000
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Semaphorin3E-Induced Inflammation Contributes to Insulin Resistance in Dietary Obesity
2013
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
1999 StandoutNobel
AGA technical review on the evaluation and management of occult and obscure gastrointestinal bleeding
2000
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
A novel functionally deficientMYH variant in individuals with colorectal adenomatous polyposis
2005
The PI3K Pathway in Human Disease
2017 Standout
American Joint Committee on Cancer prognostic factors consensus conference
2000
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Identification of stem cells in small intestine and colon by marker gene Lgr5
2007 StandoutNature
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
1995 Standout
High Prevalence of Activated Intraepithelial Cytotoxic T Lymphocytes and Increased Neoplastic Cell Apoptosis in Colorectal Carcinomas with Microsatellite Instability
1999
Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies
2014
ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes
2015
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
2006
HER2 Testing by Local, Central, and Reference Laboratories in Specimens From the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial
2006
Immunohistochemistry Versus Microsatellite Instability Testing in Phenotyping Colorectal Tumors
2002
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
SMALL INTESTINAL BLEEDING
2000
Activation of H2O2 by Chiral Confined Brønsted Acids: A Highly Enantioselective Catalytic Sulfoxidation
2012 StandoutNobel
Molecular Pathways: Sensitivity and Resistance to Anti-EGFR Antibodies
2015
Aspirin Use and Reduced Risk of Fatal Colon Cancer
1991 Standout
In Reply
2007
miR-34a repression of SIRT1 regulates apoptosis
2008
Histopathological Identification of Colon Cancer with Microsatellite Instability
2001
Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal.
2001
Tumor Budding: The Name is EMT. Partial EMT.
2016
European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication
2012
Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis.
2001
The Met pathway: master switch and drug target in cancer progression
2006
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
2003 Standout
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1.
1998
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
2008
The ubiquitin-proteasome pathway: on protein death and cell life
1998 StandoutNobel
Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases
2007
Effect of Flexible Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality
2014
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Colorectal cancer screening: a global overview of existing programmes
2015
Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer
2000
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
1998 Standout
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Biallelic inactivation of hMLH 1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers
1998 StandoutNobel
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
MutYH (MYH) and colorectal cancer
2005
Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society
2018
Diagnostic yield of push-type enteroscopy in relation to indication
1998
American Joint Committee on Cancer Prognostic Factors Consensus Conference
1999
Works of Mauro Risio being referenced
Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas
2012
HER2 testing in gastric cancer: Molecular morphology and storage time-related changes in archival samples
2003
Spontaneous and pronase‐induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines
2012
Sema3E–Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice
2010
HER2 testing and correlation with efficacy of trastuzumab therapy.
2002
Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential
1989
Immunohistochemical study of epithelial cell proliferation in hyperplastic polyps, adenomas, and adenocarcinomas of the large bowel
1988
K‐ras2 Mutation Spectrum, DNA Aneuploidy, and Epithelial Cell Proliferation in Colorectal Adenomasa
1995
In melanocytic lesions the fraction of BRAFV600E alleles is associated with sun exposure but unrelated to ERK phosphorylation
2008
An uncleavable form of pro–scatter factor suppresses tumor growth and dissemination in mice
2004
Extended Preoperative Chemotherapy Does Not Improve Pathologic Response and Increases Postoperative Liver Insufficiency After Hepatic Resection for Colorectal Liver Metastases
2010
Clinical Evaluation of Push-Type Enteroscopy
1995
Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy
2012
K‐ras2 Activation and Genome Instability Increase Proliferation and Size of FAP Adenomas
1999
Once-Only Sigmoidoscopy in Colorectal Cancer Screening: Follow-up Findings of the Italian Randomized Controlled Trial--SCORE
2011
Comparing Attendance and Detection Rate of Colonoscopy With Sigmoidoscopy and FIT for Colorectal Cancer Screening
2007
High frequency of MYH gene mutations in a subset of patients with familial adenomatous polyposis☆
2004
Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference
2015
Colorectal cancer in patients with ulcerative colitis. A prospective cohort study in Italy
1995
Deletions at chromosome 1p by fluorescence in situ hybridization are an early event in human colorectal tumorigenesis
1996
Cell proliferation in colorectal tumor progression: An immunohistochemical approach to intermediate biomarkers
1992
Impact of Surgery on the Development of Duodenal Cancer in Patients with Familial Adenomatous Polyposis
2006
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Annotations of colorectal lesions
2012
Somatic Mutations of Epidermal Growth Factor Receptor in Bile Duct and Gallbladder Carcinoma
2006
Combined DNA flow cytometry and sorting with k‐ras2 mutation spectrum analysis and the prognosis of human sporadic colorectal cancer
2002
Correlations between rectal mucosa cell proliferation and the clinical and pathological features of nonfamilial neoplasia of the large intestine.
1991
Small Bowel Tumors and Polyposis Syndromes
1999
Microsatellite instability is associated with the histological features of the tumor in nonfamilial colorectal cancer.
1996
Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases
2006
VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas
2005
Apoptosis, cell replication, and Western-style diet-induced tumorigenesis in mouse colon.
1996